We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Monitoring Device Diagnoses Irregular Heart Beat

By HospiMedica International staff writers
Posted on 31 May 2012
A new study describes the use of a novel ambulatory cardiac monitor to aid emergency department (ED) patients in avoiding unnecessary follow-up care. More...


Researchers at Scripps Memorial Hospital (La Jolla, CA, USA), Scott & White Memorial Hospital (Temple, TX, USA), and other institutions followed 285 patients who had presented to the ED with symptoms possibly related to arrhythmias, such as fainting, palpitations, and dizziness. The patients received the wire-free Zio Patch, a product of iRhythm Technologies (San Francisco, CA, USA), prior to being discharged, and were instructed to wear it until it no longer adhered to their skin – up to 14 days duration.

The devices were then mailed back to iRhythm Technologies using a prepaid postage envelope, for analysis and reporting of results to the patient's physician. The results showed that there was 100% compliance by patients, and that 59% of the symptomatic patients who presented to the emergency rooms did not have arrhythmia, and probably do not require any further work-up. The study was presented at the Heart Rhythm Society annual scientific sessions, held during May 2012 in Boston (MA, USA).

“The patch is applied and when recording is done, the patient simply drops it in the envelope and returns it through the mail – it's like the Netflix of heart care,” said lead author and study presenter Steven Higgins, MD, chairman of the department of cardiology at Scripps Memorial Hospital. “Because they are infrequent, heart rhythm problems are often difficult to diagnose, even though they can be quite serious. The Zio Patch is a new digital advance that will allow us to better diagnose challenging cases so we can provide our patients the best care.”

The Zio Patch is a long-term cardiac rhythm monitor that provides continuous monitoring for up-to-14 days, significantly longer than the time period of a typical Holter device, thus improving the likelihood of capturing arrhythmias. It is indicated for use on patients who may be asymptomatic or who may suffer from transient symptoms such as palpitations, dizziness, light-headedness, pre-syncope and syncope, shortness of breath, anxiety, and fatigue.

Related Links:

Scripps Memorial Hospital
Scott & White Memorial Hospital
iRhythm Technologies



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.